KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE
Disclosed are kinase inhibitor compounds having the following structure: (I), or a stereoisomer, pharmaceutically acceptable salt, oxide, or solvate thereof, where R1, R2, R3, R4, R5, R6, N-Ar, X, Y, Z, and AA are as defined herein. Also disclosed are compositions containing the kinase inhibitor com...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | DEVITA, Robert J KUMAR, Kunal SANCHEZ, Roberto J WANG, Hui WANG, Peng SUEBSUWONG, Chalada STEWART, Andrew F |
description | Disclosed are kinase inhibitor compounds having the following structure: (I), or a stereoisomer, pharmaceutically acceptable salt, oxide, or solvate thereof, where R1, R2, R3, R4, R5, R6, N-Ar, X, Y, Z, and AA are as defined herein. Also disclosed are compositions containing the kinase inhibitor compounds, methods of inhibiting activity of a kinase in a cell, methods of increasing cell proliferation in a population of pancreatic beta cells, methods of treating a subject for a condition associated with insufficient insulin secretion, and methods of treating a subject for a neurological disorder. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2022064146A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2022064146A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2022064146A13</originalsourceid><addsrcrecordid>eNrjZLDz9vRzDHZV8PTz8HTyDPEPUnD29w3wD_VzCVZw9HOB8II9Qzz9_SACvq4hHv5ASX83hdBgVx4G1rTEnOJUXijNzaDs5hri7KGbWpAfn1pckJicmpdaEh8abGRgZGRgZmJoYuZoaEycKgAJgisN</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE</title><source>esp@cenet</source><creator>DEVITA, Robert J ; KUMAR, Kunal ; SANCHEZ, Roberto J ; WANG, Hui ; WANG, Peng ; SUEBSUWONG, Chalada ; STEWART, Andrew F</creator><creatorcontrib>DEVITA, Robert J ; KUMAR, Kunal ; SANCHEZ, Roberto J ; WANG, Hui ; WANG, Peng ; SUEBSUWONG, Chalada ; STEWART, Andrew F</creatorcontrib><description>Disclosed are kinase inhibitor compounds having the following structure: (I), or a stereoisomer, pharmaceutically acceptable salt, oxide, or solvate thereof, where R1, R2, R3, R4, R5, R6, N-Ar, X, Y, Z, and AA are as defined herein. Also disclosed are compositions containing the kinase inhibitor compounds, methods of inhibiting activity of a kinase in a cell, methods of increasing cell proliferation in a population of pancreatic beta cells, methods of treating a subject for a condition associated with insufficient insulin secretion, and methods of treating a subject for a neurological disorder.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220303&DB=EPODOC&CC=US&NR=2022064146A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220303&DB=EPODOC&CC=US&NR=2022064146A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DEVITA, Robert J</creatorcontrib><creatorcontrib>KUMAR, Kunal</creatorcontrib><creatorcontrib>SANCHEZ, Roberto J</creatorcontrib><creatorcontrib>WANG, Hui</creatorcontrib><creatorcontrib>WANG, Peng</creatorcontrib><creatorcontrib>SUEBSUWONG, Chalada</creatorcontrib><creatorcontrib>STEWART, Andrew F</creatorcontrib><title>KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE</title><description>Disclosed are kinase inhibitor compounds having the following structure: (I), or a stereoisomer, pharmaceutically acceptable salt, oxide, or solvate thereof, where R1, R2, R3, R4, R5, R6, N-Ar, X, Y, Z, and AA are as defined herein. Also disclosed are compositions containing the kinase inhibitor compounds, methods of inhibiting activity of a kinase in a cell, methods of increasing cell proliferation in a population of pancreatic beta cells, methods of treating a subject for a condition associated with insufficient insulin secretion, and methods of treating a subject for a neurological disorder.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLDz9vRzDHZV8PTz8HTyDPEPUnD29w3wD_VzCVZw9HOB8II9Qzz9_SACvq4hHv5ASX83hdBgVx4G1rTEnOJUXijNzaDs5hri7KGbWpAfn1pckJicmpdaEh8abGRgZGRgZmJoYuZoaEycKgAJgisN</recordid><startdate>20220303</startdate><enddate>20220303</enddate><creator>DEVITA, Robert J</creator><creator>KUMAR, Kunal</creator><creator>SANCHEZ, Roberto J</creator><creator>WANG, Hui</creator><creator>WANG, Peng</creator><creator>SUEBSUWONG, Chalada</creator><creator>STEWART, Andrew F</creator><scope>EVB</scope></search><sort><creationdate>20220303</creationdate><title>KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE</title><author>DEVITA, Robert J ; KUMAR, Kunal ; SANCHEZ, Roberto J ; WANG, Hui ; WANG, Peng ; SUEBSUWONG, Chalada ; STEWART, Andrew F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2022064146A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>DEVITA, Robert J</creatorcontrib><creatorcontrib>KUMAR, Kunal</creatorcontrib><creatorcontrib>SANCHEZ, Roberto J</creatorcontrib><creatorcontrib>WANG, Hui</creatorcontrib><creatorcontrib>WANG, Peng</creatorcontrib><creatorcontrib>SUEBSUWONG, Chalada</creatorcontrib><creatorcontrib>STEWART, Andrew F</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DEVITA, Robert J</au><au>KUMAR, Kunal</au><au>SANCHEZ, Roberto J</au><au>WANG, Hui</au><au>WANG, Peng</au><au>SUEBSUWONG, Chalada</au><au>STEWART, Andrew F</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE</title><date>2022-03-03</date><risdate>2022</risdate><abstract>Disclosed are kinase inhibitor compounds having the following structure: (I), or a stereoisomer, pharmaceutically acceptable salt, oxide, or solvate thereof, where R1, R2, R3, R4, R5, R6, N-Ar, X, Y, Z, and AA are as defined herein. Also disclosed are compositions containing the kinase inhibitor compounds, methods of inhibiting activity of a kinase in a cell, methods of increasing cell proliferation in a population of pancreatic beta cells, methods of treating a subject for a condition associated with insufficient insulin secretion, and methods of treating a subject for a neurological disorder.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US2022064146A1 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T01%3A55%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DEVITA,%20Robert%20J&rft.date=2022-03-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2022064146A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |